Outrun Therapeutics Is A Biotechnology Company Dedicated To Developing Small Molecule Inhibitors That Target E3 Ligasesthis Innovative Approach Aims To Stabilize Proteins And Treat Diseasesparticularly Canceroriginating From Profsatpal Virdeeae S Lab At The University Of Dundeeoutrun Leverages Extensive Expertise In E3 Ligase Biology To Tackle Challenges In Protein Stabilization The Company Utilizes Its Proprietary Xe3L Platform To Discover First In Class E3 Ligase Inhibitorsthis Platform Integrates Structural Biologycomputational Toolsand Medicinal Chemistry To Target E3 Ligases That Have Historically Been Difficult To Drugoutrun S Lead Program Focuses On Inhibiting An E3 Ligase That Destabilizes A Tumor Suppressor Protein In Challenging Solid Tumorswith The Goal Of Reactivating Natural Anti Cancer Mechanismsthe Company Is Backed By M Ventures And Mp Healthcare Venture Managementhaving Secured $10 Million In Seed Financing In April 2024
| Company Name | Outrun Therapeutics Ltd |
| Country |
United Kingdom
|
| Address | N/A |
| Telephone | N/A |
| N/A |
United States